Patents Assigned to GENOSCIENCE
  • Specific HCV NS3 protease inhibitors
    Patent number: 8729014
    Abstract: The present invention is directed to compounds, compositions and methods for treating or preventing viral infections, in particular, HCV in human patients or other animal hosts.
    Type: Grant
    Filed: October 28, 2011
    Date of Patent: May 20, 2014
    Assignees: RFS Pharma, LLC, Genoscience
    Inventors: Jerome Courcambeck, Philippe Halfon, Mourad Bouzidi, Steven J. Coats, Richard Anthony Whitaker
  • NOVEL SPECIFIC HCV NS3 PROTEASE INHIBITORS
    Publication number: 20120129765
    Abstract: The present invention is directed to compounds, compositions and methods for treating or preventing viral infections, in particular, HCV in human patients or other animal hosts.
    Type: Application
    Filed: October 28, 2011
    Publication date: May 24, 2012
    Applicants: GENOSCIENCE, RFS Pharma, LLC
    Inventors: Jerome Courcambeck, Philippe Halfon, Mourad Bouzidi, Steven J. Coats, Richard Anthony Whitaker
  • Pyrrolidine derivatives for use in treating heaptitis c virus infection
    Publication number: 20060142204
    Abstract: The present invention relates to novel hepatitis C virus (“HCV”) protease inhibitors or other flavivirus protease inhibitors having the general structure (I) or (II), pharmaceutical compositions containing one or more such inhibitors, methods for preparing such inhibitors, uses of these compounds to treat hepatitis C and related disorders together with their use for their activity towards NS3 serine protease, intermediary compounds for the method of preparation of said compounds and screening methods. The invention specifically discloses novel chemical compounds as inhibitors of the HCV serine protease.
    Type: Application
    Filed: October 9, 2003
    Publication date: June 29, 2006
    Applicant: GENOSCIENCE
    Inventors: Philippe Halfon, Chalom Sayada, Jean-Marc Feryn, Regis Perbost, Frederic Garzino, Michel Camplo, Jerome Courcambeck, Gerard Pepe